EUVIMEDEUVIMED entdecken
Übersichtsarbeit

IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs

Minglei Li iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400365 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, 2024. Verfasst von Minglei Li. Beteiligte Einrichtung: Chemical Biology Center, School of Pharmaceutical Sciences & Institute of Materia Medical, Shandong First Medical University & Shandong Academy of Me…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Proteolysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Postdoctoral Innovation Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis‐targeting chimera (PROTAC) has become a very important means of protein degradation and a new way of disease treatment. In particular, PROTACs constructed with ligands for E3 ligase cereblon account for more than 90 % of the PROTACs currently in clinical research. Notably, CRBN ligands themselves are a class of molecular glue compounds capable of degrading neo‐substrate proteins. Compared to the target proteins degradation, the degradation of neo‐substrates, especially IKZF2, has not received enough attention. Therefore, this review summarizes the currently published IKZF2 degraders derived from articles and patents, which are conducive to the design of PROTACs with desired IKZF2 degradation from the perspective of medicinal chemistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesProteolysisHumansDrug DesignAdaptor Proteins, Signal TransducingLigandsIkaros Transcription FactorProteolysis Targeting Chimera

Stichwörter der Autor:innen

IKZF2PROTACscereblonmolecular glueprotein degradation

Substanzen

Ubiquitin-Protein LigasesCRBN protein, humanAdaptor Proteins, Signal TransducingLigandsIkaros Transcription FactorProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Chemical Biology Center, School of Pharmaceutical Sciences & Institute of Materia Medical, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
  • School of Pharmaceutical Sciences & Institute of Materia Medical, Shandong First Medical University & Shandong Academy of Medical Sciences, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Bi…

ORCID-Profile: Minglei Li

Förderung

  • Postdoctoral Innovation Project of Shandong Province

Zitieren

APA

Li, M. (2024). IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs. ChemBioChem. https://doi.org/10.1002/cbic.202400365

Vancouver

Li M. IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs. ChemBioChem. 2024. doi:10.1002/cbic.202400365

BibTeX
@article{Li2024,
  author = {Li, Minglei},
  title = {IKZF2 Degradation: It′s Time to Take into Account it When Designing Cereblon‐Based PROTACs},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400365}
}
Kostenlos starten →